Shares in regenerative medicine company Osteopore soar on Singapore, Vietnam market approvals

Shares in Osteopore rallied as high as 900 per cent after the medtech company announced it had secured market approvals for its orthopaedic products in Singapore and Vietnam.

Singapore-founded but Perth-based Osteopore on Wednesday announced it had obtained regulatory clearance from Singapore’s Health Sciences Authority and Vietnam’s Department of Medical Equipment and Construction for aXOpore, which includes a suite of off-the-shelf and customisable orthopaedic products.